Tanner Pharma
Tanner Pharma is a privately-held pharma services company that designs and operates global access programs, clinical trial supply chains, and licensed pharmaceutical distribution for biopharma sponsors across 155+ countries.
- Company typePrivate
- Founded1999
- HeadquartersCharlotte, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Tanner Pharma does
Tanner Pharma Group, Inc. is a privately-held pharmaceutical services company founded in 1999 by Banks Bourne and headquartered in Charlotte, NC. The firm operates through three core service lines delivered under wholly-owned subsidiaries: TannerLAC (licensing, acquisitions, and commercialization for emerging markets), TannerGAP (global access programs including named-patient supply, compassionate use, and early access), and TannerCTS (clinical trial sourcing of comparators, bioanalytical, and biologic products, plus secondary packaging and labeling). Together these address the global access gap affecting nearly 2 billion people who lack access to essential medicines, providing compliant pathways for biopharmaceutical sponsors to reach patients in markets where treatments are not commercially available, have been withdrawn, or face supply shortages.
The company's core technology is a GDP-compliant pharmaceutical distribution and supply-chain platform combining temperature-controlled cold-chain logistics (2-8°C), EPCIS-enabled real-time product tracking, EDI systems integration for order processing, and a quality management system aligned with regulatory standards across multiple jurisdictions. Tanner maintains licensed operations in the US (NCAGR), UK (MHRA GDP and MIA(IMP)), Ireland (HPRA wholesaler and MIA), and Switzerland (Swissmedic establishment), with distribution reach extending to 155+ countries via owned warehouses and contracted logistics partners. Differentiated capabilities include cold-chain clinical-trial supply for biologics and rare-disease therapies, secondary packaging and labeling, comparator drug sourcing, and real-world data capture alongside access-program delivery.
Tanner generates revenue through a B2B enterprise sales motion targeting biopharmaceutical companies, clinical trial sponsors, healthcare providers, NGOs, and ministries of health. Revenue streams span professional services (program management and regulatory compliance fees for access programs), managed services (sourcing, packaging, and logistics for clinical trials), and transaction fees (commercial distribution, tender supply, and importation). Pricing is bespoke and quote-based with no public disclosure; revenue allocation includes a charitable contribution through the TannerCares program. The company is founder-controlled, privately held with no disclosed institutional funding, and operates 101-250 employees across the US, UK, Ireland, and Switzerland.
Tanner Pharma firmographics
Firmographics- Name
- Tanner Pharma
- Legal name
- Tanner Pharma Group, Inc.
- Website
- https://tannerpharma.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Tanner Pharma is a privately-held pharma services company that designs and operates global access programs, clinical trial supply chains, and licensed pharmaceutical distribution for biopharma sponsors across 155+ countries.
- Ownership category
- akta.pro rank
Tanner Pharma industry classification
Industry- Product category
- Pharmaceutical Access Services
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
- akta.pro secondary industries
- Specialty Pharmaceutical Distributors (HLAIAJAB), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
Keywords
Where Tanner Pharma is headquartered
LocationHeadquarters
- HQ city
- Charlotte
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Tanner Pharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Access Solutions Services: Provides compliant pharmaceutical access solutions including compassionate use programs, named patient programs, market withdrawal support, and emergency supply services to biopharmaceutical companies. Revenue generated through service fees for program management, regulatory compliance, and distribution services.
- Clinical Trial Solutions: Comparator drug sourcing, procurement, secondary packaging, labeling, and GDP-compliant storage and distribution for clinical trials. Revenue from sourcing fees, logistics services, and value-added packaging services.
- Commercial Distribution: Global pharmaceutical distribution including tender supply, commercial importation, and ongoing supply to hospitals, pharmacies, and ministries of health.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Tanner Pharma product offering
Product offeringCore offering
Tanner Pharma provides global pharmaceutical access solutions and clinical trial supply chain services for biopharmaceutical companies. Its core offerings include compassionate use, named patient, and protocol-based access programs, post-trial and donation programs, market withdrawal/shortage response, and commercial distribution/tender supply under its Access Solutions business. Its Clinical Trial Solutions cover comparator drug sourcing and procurement of bioanalytical/biologic materials, secondary packaging, labeling and kitting, and GDP-compliant temperature-controlled storage and distribution across 155+ countries.
Differentiator
Problem solved
Functional benefit
Products and services
- Access Solutions Compliant, tailored access solutions that remove treatment barriers and deliver therapies to patients worldwide; covers compassionate use, named patient and protocol-based access programs, post-trial supply, donation programs, market withdrawal/shortage response, and commercial distribution. Serves biopharmaceutical companies ranging from emerging biotech to global pharma that need to deliver therapies in markets without marketing authorization.
- Clinical Trial Solutions End-to-end clinical trial supply chain services for life sciences innovators, including comparator drug sourcing and procurement of bioanalytical/biologic materials, secondary packaging/labeling/kitting, GDP-compliant temperature-controlled storage and distribution, and urgent packaging rework. Serves clinical trial sponsors and biotech companies running multi-country trials.
- Compassionate Use and Named Patient Programs Programs that provide individual patients with access to investigational or unauthorized medicines on a named-patient or compassionate use basis, managed compliantly across regulatory jurisdictions. Used by biopharmaceutical companies and treating physicians when no authorized alternative exists.
- Comparator Drug Sourcing and Procurement Sourcing of comparator drugs and bioanalytical/biologic reference materials for clinical trials across global markets, including multi-lot and multi-country procurement under tight timelines. Used by clinical trial sponsors and CROs running Phase II-III studies.
- Cold-Chain Clinical Trial Supply (2-8°C) GDP-compliant, temperature-controlled (2-8°C) storage and distribution of clinical trial materials with specialized courier solutions across multiple countries. Used by sponsors of temperature-sensitive biologics and advanced therapy trials.
- Medicine Donation Programs Compliant design, management, and distribution of pharmaceutical donation programs targeting underserved patient populations in low- and middle-income countries. Used by NGOs, ministries of health, and biopharmaceutical donors supporting access to chronic and rare disease therapies.
- eRapa Global Early Access Program Global Early Access/Named Patient Program for eRapa, an investigational oral therapy for Familial Adenomatous Polyposis (FAP). Delivered in partnership with Biodexa Pharmaceuticals to provide compliant, controlled access to the investigational therapy in countries where it is not commercially available, while generating Real World Data.
Quantifiable outcome
- 30,000 patients reached through global donation program across 80 countries
- +4 more outcomes
Companies that use Tanner Pharma
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Tanner Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Tanner Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Biodexa Pharmaceuticals PLCcoreStrategic partnership to launch a global Early Access/Named Patient Program for eRapa, an investigational oral therapy for Familial Adenomatous Polyposis (FAP). Tanner Pharma facilitates compliant, controlled access to eRapa in countries where it is not commercially available. Biodexa generates Real World Data as part of the initiative. This is the first time the investigational medicine will be prescribed outside of clinical trials.
Scale indicators7 records
Recent moves5 records
Expansion highlights6 records
Tanner Pharma competitors and assessment
Company assessmentDirect peers
- Myonex: Global clinical trial supply services company providing comparator sourcing, packaging, labeling, and distribution for clinical trials — directly comparable to Tanner's Clinical Trial Solutions division.
- Clinigen Group: UK-based global pharmaceutical services company specializing in managed access programs (named patient, compassionate use), clinical trial supply, and unlicensed medicines — directly overlapping Tanner's access solutions and clinical trial supply offerings.
- BAP Pharma: Specializes in comparator sourcing and clinical trial supply for the pharmaceutical industry, with a focus on difficult-to-source medicines — directly comparable to Tanner's TannerCTS comparator sourcing business.
- AnovoRx: Specialty pharmaceutical distributor focused on patient access programs, rare disease therapies, and limited distribution drugs — comparable to Tanner's TannerGAP and TannerLAC access-focused businesses.
Broad incumbents
- IQVIA: Largest global CRO and clinical trial services provider with broad capabilities in clinical supply, commercial distribution, and real-world evidence — overlaps with Tanner across multiple service lines but at much greater scale.
- Thermo Fisher Scientific (Clinical Trial Services): Through Patheon and clinical supply services, offers comparator sourcing, packaging, labeling, and global distribution — broad incumbent in clinical trial supply adjacent to Tanner's CTS offerings.
- McKesson: Major pharmaceutical wholesaler and specialty distribution operator with global reach and access services — broad incumbent whose specialty distribution business overlaps with Tanner's commercial distribution segment.
- Cencora (formerly AmerisourceBergen): One of the largest pharmaceutical distributors globally with specialty distribution, patient access services, and consulting — overlaps with Tanner's commercial distribution and access solutions but at vastly greater scale.
Others
- DHL Supply Chain (Life Sciences & Healthcare): Global logistics provider with GDP-compliant pharmaceutical distribution and cold chain capabilities — comparable as a contracted logistics partner and infrastructure provider supporting Tanner's broader 3PL network.
Emerging players
- RxLogix: Provides patient access, named patient program, and safety case management technology for pharmaceutical companies — partial overlap with Tanner's digital and operational infrastructure for access programs.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Tanner Pharma social profiles
Digital presenceTanner Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tanner Pharma leadership team
Management profileNumber of profiles
Profiles2 records
Tanner Pharma subsidiaries and ownership
Company hierarchySubsidiaries7 records
Tanner Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tanner Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tanner Pharma
What does Tanner Pharma do?
Tanner Pharma provides global pharmaceutical access solutions and clinical trial supply chain services for biopharmaceutical companies. Its core offerings include compassionate use, named patient, and protocol-based access programs, post-trial and donation programs, market withdrawal/shortage response, and commercial distribution/tender supply under its Access Solutions business. Its Clinical Trial Solutions cover comparator drug sourcing and procurement of bioanalytical/biologic materials, secondary packaging, labeling and kitting, and GDP-compliant temperature-controlled storage and distribution across 155+ countries.
Is Tanner Pharma a public or private company?
Tanner Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Tanner Pharma founded?
Tanner Pharma was founded in 1999. It employs 101 to 250 people.
Where is Tanner Pharma based?
Tanner Pharma is headquartered in Charlotte, United States, in the North America region.
How does Tanner Pharma make money?
Three revenue lines are on record. Access Solutions Services are the primary driver. The others are clinical Trial Solutions and commercial Distribution.
Who are Tanner Pharma's main competitors?
Direct peers on record are Myonex, Clinigen Group, BAP Pharma and AnovoRx. Broad incumbents are IQVIA, Thermo Fisher Scientific (Clinical Trial Services), McKesson and Cencora (formerly AmerisourceBergen). DHL Supply Chain (Life Sciences & Healthcare) is listed as an others. RxLogix is listed as an emerging player.
Does Tanner Pharma have an API?
No public API is recorded for Tanner Pharma.
What industry is Tanner Pharma in?
Tanner Pharma's product category is Pharmaceutical Access Services. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of HLAIAJAB, Specialty Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.